RE:RE:RE:General question for the board I beg to differ! CGON has BTD for the same indication and has a MC of $2.5 Billion USD! They have 300 million in cash, but don't have virus inactivation, they don't have possibility to treat All solid tumors! We could reach at least a third of their valuation initially I hope. That would be 500 million to 1 Billion MC CAD. 1.50-3$ per share. Just IMO
Bigkahuna57 wrote: I'd guess the BTD approval, while signifcant as a necessary step in the progress toward FDA approval doesn't move the SP much. It's critically important b/c it leads to AA. And I'd appreciate having BTD very soon, I just don't think there's will be enough volume share turnover to elevate the SP and keep it above where we are. Now, IMO AA permits us to generate revenue and THAT should create more interest and move SP higher. I hope BTD is a catalyst for a higher SP and I'm wrong for everyone's benefit.
GLTA
Regards,BK